Export to Excel Export to OpenOffice.org Print version

Sanofi (SNY) | Statement of Cash Flows

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Sanofi, Consolidated Statement of Cash Flows

USD $ in millions, translated from EUR €

Export to Excel Export to OpenOffice.org
  12 months ended Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Net income attributable to equity holders of Sanofi
chart Net income from the held-for-exchange Merial business
chart Dividends received from Merial
chart Non-controlling interests, excluding BMS
chart Share of undistributed earnings of associates and joint ventures
chart Depreciation, amortization and impairment of property, plant and equipment and intangible assets
chart Gains and losses on disposals of non-current assets, net of tax
chart Net change in deferred taxes
chart Net change in provisions
chart Cost of employee benefits (stock options and other share-based payments)
chart Impact of the workdown of acquired inventories remeasured at fair value
chart Unrealized (gains) losses recognized in income
chart Operating cash flow before changes in working capital
chart (Increase) decrease in inventories
chart (Increase) decrease in accounts receivable
chart Increase (decrease) in accounts payable
chart Net change in other current assets, current financial assets and other current liabilities
chart Changes in working capital
chart Net cash provided by (used in) operating activities
chart Acquisitions of property, plant and equipment and intangible assets
chart Acquisitions of investments in consolidated undertakings, net of cash acquired
chart Acquisitions of available-for-sale financial assets
chart Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax
chart Net change in loans and other financial assets
chart Net cash provided by (used in) investing activities
chart Issuance of Sanofi shares
chart Dividends paid to shareholders of Sanofi
chart Dividends paid to non-controlling shareholders, excluding BMS
chart Transactions with non-controlling interests, other than dividends
chart Additional long-term debt contracted
chart Repayments of long-term debt
chart Net change in short-term debt
chart Acquisition of treasury shares
chart Disposals of treasury shares, net of tax
chart Net cash provided by (used in) financing activities
chart Impact of exchange rates on cash and cash equivalents
chart Impact of Merial cash and cash equivalents
chart Net change in cash and cash equivalents
chart Cash and cash equivalents, beginning of period
chart Cash and cash equivalents, end of period
Source: Sanofi, Annual Reports
Item Description The company
Net cash provided by (used in) operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Sanofi's net cash provided by (used in) operating activities increased from 2009 to 2010 but then declined significantly from 2010 to 2011.

May 24, 2012

Existing users sign in

Forgot your password?